Risks of biologic therapy and the importance of multidisciplinary approach for an accurate management of patients with moderate-severe psoriasis and concomitant …

A Ion, AM Dorobanțu, LG Popa, MM Mihai, OA Orzan - Biology, 2022 - mdpi.com
Simple Summary Psoriasis is a chronic multisystem inflammatory disease associated with a
wide range of comorbidities including cardiovascular disease, hypertension, diabetes …

Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities

L Mateu-Arrom, L Puig - Expert Review of Clinical Pharmacology, 2024 - Taylor & Francis
Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …

How can we manage the safety concerns associated with the increase in biologics for psoriasis?

A Silfvast-Kaiser, MA Menter - Expert Opinion on Drug Safety, 2020 - Taylor & Francis
Psoriasis is a chronic, systemic, inflammatory disease affecting 2-3% of the worldwide
population. It is associated with multiple comorbidities including cardiovascular disease …

Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review

Y Wang, P Zhang, Y Lv, Y Deng, M Yao… - Clinical, Cosmetic …, 2023 - Taylor & Francis
This literature review systematically searched relevant literature from the past 10 years using
various medical databases, including PubMed, Medline, Cochrane, China National …

Current and emerging systemic treatment strategies for psoriasis

PM Laws, HS Young - Drugs, 2012 - Springer
Psoriasis is a common chronic inflammatory disease of the skin that has a significant impact
on quality of life. A small number of systemic therapies are well established in psoriasis …

Biologic treatment algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: a review

A Thatiparthi, A Martin, J Liu, A Egeberg… - American Journal of …, 2021 - Springer
The emergence of data from clinical trials of biologics, the approval of new biologics, and
our improved understanding of psoriasis pathogenesis have increased the therapeutic …

Psoriasis: behind the scenes

M Furue, T Kadono - The Journal of Dermatology, 2016 - Wiley Online Library
Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration
in the quality of life of affected individuals. Notably, psoriasis is significantly associated with …

Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome

E Trovato, P Rubegni, F Prignano - Expert Opinion on Biological …, 2022 - Taylor & Francis
Introduction Psoriasis is an inflammatory disease nowadays considered not only as a
cutaneous but as a systemic disease. Among the numerous comorbidities, psoriatic arthritis …

Novel therapeutic approaches to psoriasis and risk of infectious disease

A Motolese, M Ceccarelli, L Macca, F Li Pomi… - Biomedicines, 2022 - mdpi.com
Psoriasis is a chronic immune-mediated skin and joint disease, with a plethora of
comorbidities, characterized by a certain genetic predisposition, and a complex …

[HTML][HTML] State of the Art Review on the Treatment of Psoriatic Disease

E Pelechas, E Kaltsonoudis, MP Migkos… - Mediterranean …, 2024 - ncbi.nlm.nih.gov
Introduction: Psoriasis is an inflammatory skin disease that in some cases is accompanied
by systemic manifestations. Given the varied clinical manifestations, the term psoriatic …